NCT03266055

Brief Summary

There is growing evidence that nutritional intervention with dietary polyphenols can positively modulate the gut microbiota to improve cardiometabolic health. Whether the beneficial effects of blueberries on obesity and the metabolic syndrome can be linked to their potential impact on the gut microbiota and intestinal integrity remains speculative at this time. Moreover, the mechanisms of action underlying health benefits associated to blueberry consumption are still unknown. The investigators are thus proposing to combine the study of metagenomics, transcriptomics and metabolomics to test whether a prebiotic activity of highbush blueberries can play a role in the prevention of obesity-linked metabolic syndrome in a clinical setting.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 29, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2019

Completed
6.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

July 6, 2017

Last Update Submit

December 19, 2025

Conditions

Keywords

BlueberryDiet

Outcome Measures

Primary Outcomes (2)

  • Changes in plasma insulin/glucose of overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    12 months

  • Changes in plasma lipids/lipoproteins of overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    12 months

Secondary Outcomes (6)

  • Changes in gene expression in overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    3-6 months

  • Changes in metabolites concentration in overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    3-6 months

  • Changes in the gut microbiota composition in overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    3-6 months

  • Changes in blood pressure of overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    12 months

  • Changes in intestinal integrity of overweight/obese men and women taking either blueberry powder or placebo blueberry powder

    12 months

  • +1 more secondary outcomes

Study Arms (2)

Blueberry powder

EXPERIMENTAL
Dietary Supplement: 50 g of blueberry powder, taken daily for 8 weeks

Blueberry placebo powder

PLACEBO COMPARATOR
Dietary Supplement: 50g of placebo blueberry powder, taken daily for 8 weeks

Interventions

Subjects will consume blueberry powder during 8 weeks to test the possible effects of blueberries on gut microbiota composition and on metabolic syndrome parameters.

Blueberry powder

Subjects will consume blueberry placebo powder to test if there is a significant difference on the impact on gut microbiota composition and metabolic syndrome parameters between this treatment and the active treatment (blueberry powder).

Blueberry placebo powder

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and premenopause women in good health
  • Caucasians
  • At least one of the following : BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
  • At least one of the following : TG ≥ 1.35 mmol/L or fasting insulinemia ≥ 42 pmol/L

You may not qualify if:

  • Metabolic disorders (hypertension, diabetes, hypercholesterolemia)
  • Regular use of medication affecting study parameters
  • Use of natural health product in the last 3 months
  • Use of antibiotics in the last 3 months
  • Nicotine users
  • Allergy or intolerance for blueberries
  • Blueberry taste aversion
  • More than 2 alcohol drinks par day
  • Particular dietary habits (vegetarism, gluten-free diet, cetogenic diet...)
  • Weight change of more than 5% in the last 3 months
  • Surgery in the last 3 months or planed during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laval University

Québec, G1V0A6, Canada

Location

Related Publications (1)

  • Rousseau M, Horne J, Guenard F, de Toro-Martin J, Garneau V, Guay V, Kearney M, Pilon G, Roy D, Couture P, Couillard C, Marette A, Vohl MC. An 8-week freeze-dried blueberry supplement impacts immune-related pathways: a randomized, double-blind placebo-controlled trial. Genes Nutr. 2021 May 17;16(1):7. doi: 10.1186/s12263-021-00688-2.

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Marie-Claude Vohl

    Laval University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 6, 2017

First Posted

August 29, 2017

Study Start

September 1, 2017

Primary Completion

January 14, 2019

Study Completion

December 1, 2025

Last Updated

December 26, 2025

Record last verified: 2025-12

Locations